Clinical Trial Update: Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study [Phase 2]

View source ↗

Summary

A Phase 2 long-term treatment study (Effisayil ON) is evaluating spesolimab in people with generalized pustular psoriasis who participated in a prior trial; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Pustular Psoriasis

Drugs mentioned

• SPESOLIMAB (BI655130)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Generalized Pustular Psoriasis | Phase 2 | Status: ACTIVE_NOT_RECRUITING